Loretta Nastoupil
MD Anderson Cancer Center, Texas
Loretta Nastoupil
MD Anderson Cancer Center, Texas
Associate Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Lymphoma Outcomes Database, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Section Chief, New Drug Development, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Topic: Clinical Management and Advances in Chimeric Antigen Receptor T-cell (CAR T) therapy for lymphomas
Loreta Nastoupil
MD Anderson Cancer Center, Texas
Catherine Thieblemont
Hôpital Saint-Louis, Paris
Catherine Thieblemont
Hôpital Saint-Louis, Paris
Professor of Haematology in the Paris University, chair of the Lymphoma group at Hospital Saint-Louis, and head of the hemato-oncology department-Paris, France
Prof Thieblemont ‘s major interest is the biological and clinical features of lymphomas. She is involved in clinical trials for the treatment of lymphoma patients, particularly integrating innovative treatments, such cell immunotherapies and CAR T-cells.
Topic: Updates in Marginal Zone Lymphoma
Catherine Thieblemont
Hôpital Saint-Louis, Paris
Dr. Loreta Nastoupil
Speaker presentation
Dr. Catherine Thieblemont
Speaker presentation
Faculty Q&A
Dr. Loreta Nastoupil
60 second overview
Dr. Catherine Thieblemont
60 second overview
Downloadable PDF
CME Post-test (January)
Please complete the questions below, after viewing the video, if you would like to receive CME credits. Once you have completed the pre-test, watched the video and completed the post-test, your certificate will be emailed to you within 7 days.
UK OFFICE
US OFFICE